Skip to content Skip to footer

Innovent Announces First Patient Dosed in A Phase 1 Clinical Trial of Anti-TIGIT Monoclonal Antibody in China

Langgan

Surat Berita

订阅我们的月讯

Subscribe to our

Newsletter